$LFMD News

LifeMD To Launch Program For XYOSTED Injection

LifeMD: A Growing Healthcare Tech Stock, As Q1 Results Confirm Patient Demand

HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $10 Price Target

GLP-1 Users Turn to Telehealth to Access Weight Loss Drugs

LifeMD to Participate in Upcoming Investor Conferences

LifeMD, Inc. Q1 2026 Earnings Call Summary

LifeMD Q1 Earnings Call Highlights

LifeMD (NASDAQ:LFMD) Q1 Beats Fails to Halt 13% After-Market Slide

LifeMD (LFMD) Q1 2026 Earnings Transcript

LifeMD Reports First Quarter 2026 Results

LifeMD Affirms FY2026 Sales Guidance of $220.000M-$230.000M vs $223.588M Est

LifeMD Sees Q2 Sales $47.000M-$50.000M vs $53.989M Est

LifeMD Q1 EPS $(0.20) Beats $(0.23) Estimate, Sales $50.163M Beat $48.842M Estimate

BTIG Reiterates Buy on LifeMD, Maintains $10 Price Target

How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth And 2026 Expectations

LifeMD to Report First Quarter 2026 Financial Results on May 6

How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth Plans And 2026 Expectations

LifeMD Now Offers Eli Lilly's Foundayo To Eligible Patients Through Its Weight Management Program

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock